PubRank

Douglas W Ball

Author PubWeight™ 40.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 2003 5.36
2 Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer. J Clin Oncol 2011 3.31
3 Notch inhibits Ptf1 function and acinar cell differentiation in developing mouse and zebrafish pancreas. Development 2004 2.21
4 Thyroid carcinoma. J Natl Compr Canc Netw 2010 2.02
5 Notch in lung development and lung cancer. Semin Cancer Biol 2004 1.73
6 Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells. Cancer Res 2006 1.65
7 Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer. Cancer Res 2009 1.55
8 Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling. Cancer Res 2010 1.54
9 Notch signaling induces rapid degradation of achaete-scute homolog 1. Mol Cell Biol 2002 1.51
10 The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway. Mol Cell Biol 2003 1.44
11 Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling. J Clin Endocrinol Metab 2005 1.39
12 Dual inhibition of mitogen-activated protein kinase kinase and mammalian target of rapamycin in differentiated and anaplastic thyroid cancer. J Clin Endocrinol Metab 2009 1.38
13 NCCN task force: clinical utility of PET in a variety of tumor types. J Natl Compr Canc Netw 2009 1.24
14 Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS. J Clin Endocrinol Metab 2012 1.21
15 Thyroid carcinoma. J Natl Compr Canc Netw 2007 1.13
16 Synergistic action of a RAF inhibitor and a dual PI3K/mTOR inhibitor in thyroid cancer. Clin Cancer Res 2011 1.13
17 Clinical review: Incidentally discovered medullary thyroid cancer: diagnostic strategies and treatment. J Clin Endocrinol Metab 2011 1.11
18 Thyroid carcinoma. J Natl Compr Canc Netw 2005 1.04
19 Insights into the achaete-scute homolog-1 gene (hASH1) in normal and neoplastic human lung. Lung Cancer 2012 0.98
20 Medullary carcinoma. J Natl Compr Canc Netw 2010 0.97
21 CEP-701 and CEP-751 inhibit constitutively activated RET tyrosine kinase activity and block medullary thyroid carcinoma cell growth. Cancer Res 2003 0.96
22 Interleukin-1beta can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells. Cytokine 2004 0.92
23 American Thyroid Association guidelines for management of medullary thyroid cancer: an adult endocrinology perspective. Thyroid 2009 0.89
24 Selectively targeting mutant BRAF in thyroid cancer. J Clin Endocrinol Metab 2010 0.85
25 GDNF-induced leukemia inhibitory factor can mediate differentiation via the MEK/ERK pathway in pheochromocytoma cells derived from nf1-heterozygous knockout mice. Exp Cell Res 2005 0.83
26 Activity of irinotecan and the tyrosine kinase inhibitor CEP-751 in medullary thyroid cancer. J Clin Endocrinol Metab 2005 0.82
27 Notch in malignancy. Cancer Treat Res 2003 0.82
28 Unusual case of metastatic neuroendocrine tumor. Endocr Pract 2007 0.79
29 Anaplastic Thyroid Carcinoma, Version 2.2015. J Natl Compr Canc Netw 2015 0.78
30 Serendipity in the diagnosis of pheochromocytoma. J Comput Assist Tomogr 2013 0.75